New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva Reports Second Quarter 2021 Financial Results | Business Wire
Teva's Austedo, struggling from a pandemic slowdown, needs huge gains to meet 2021 projections | Fierce Pharma
Austedo - FDA prescribing information, side effects and uses
Austedo for Huntington's disease: Teva Pharmaceuticals has found a nifty way to keep drugs in your body for longer — Quartz
2020 Pharma Choice DTC/DTP Silver Winner Intouch Group and Teva | PM360
FDA approves first deuterated drug
Buy Austedo (deutetrabenazine) Online • Price & Costs | TheSocialMedwork
Teva launches first DTC for Austedo into competitive tardive dyskinesia 2-drug market | Fierce Pharma
AUSTEDO® (deutetrabenazine) tablets: Tardive Dyskinesia and Huntington's Chorea Treatment
2020 Pharma Choice DTC/DTP Silver Winner Intouch Group and Teva | PM360
Israel's Teva gets China's green light for Huntington's treatment | The Times of Israel
Teva Launches 'It's Not OK - It's TD' National Television Advertising Campaign to Increase Awareness of Tardive Dyskinesia and AUSTEDO® (deutetrabenazine) tablets
FDA expands use of Austedo to tardive dyskinesia in adults
Austedo (deutetrabenazine) for the Treatment of Chorea Associated with Huntington's Disease - Clinical Trials Arena
Teva's Austedo is first 'heavy hydrogen' drug to win US FDA approval
Teva settles patent dispute with Lupin over Austedo (NYSE:TEVA) | Seeking Alpha
Deutetrabenazine - Wikipedia
Teva announces FDA approval of Austedo tablets for chorea associated with huntington's disease - Pharma Advancement
Rx Item-Austedo Tab 12Mg 60 By Teva Pharma
NDC 68546-171 Austedo Deutetrabenazine
Tardive Dyskinesia Treatment, Causes, & Symptoms
Punit on Twitter: "Teva hiked the price of #Austedo by ~6% in Jan.2021 Cost of treatment in US~ $60,000 a yr/patient 9MFY20 sales~ $451M (up 64% vs 2019) Tardive dyskinesia affects~ 500,000
Teva Announces FDA Approval of AUSTEDO™ (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington's Disease
